| 1 |
Jemal A,Siegel R,Ward E,et al.Cancer statistics,2006.CA Cancer J Clin,2006,56(2):106-130.
|
| 2 |
Yu KD,Di GH,Wu J,et al.Development and trends of surgical modalities for breast cancer in China:a review of 16-year data.Ann Surg Oncol, 2007,14(9):2502-2509.
|
| 3 |
Walsh T,King MC.Ten genes for inherited breast cancer.Cancer Cell,2007,11(2):103-105.
|
| 4 |
Yager JD,Davidson NE.Estrogen carcinogenesis in breast cancer.N Engl J Med,2006,354(3):270-282.
|
| 5 |
Hu Z,Song CG,Lu JS,et al.A multigenic study on breast cancer risk associated with genetic polymorphisms of ER Alpha,COMT and CYP 19 gene in BRCA1/BRCA2 negative Shanghai women with early onset breast cancer or affected relatives.J Cancer Res Clin Oncol,2007,133(12):969-978.
|
| 6 |
Sun T,Gao Y,Tan W,et al.A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers.Nat Genet,2007,39(5):605-613.
|
| 7 |
Cheng TC,Chen ST,Huang CS,et al.Breast cancer risk associated with genotype polymorphism of the catechol estrogen-metabolizing genes: a multigenic study on cancer susceptibility.Int J Cancer,2005,113(3):345-353.
|
| 8 |
Pearson WR,Vorachek WR,Xu SJ,et al.Identification of class-mu glutathione transferase genes GSTM1-GSTM5 on human chromosome 1p13.Am J Hum Genet,1993,53(1):220-233.
|
| 9 |
Xu S,Wang Y,Roe B,et al.Characterization of the human class Mu glutathione S-transferase gene cluster and the GSTM1 deletion.J Biol Chem,1998,273(6):3517-3527.
|
| 10 |
Egan KM,Cai Q,Shu XO,et al.Genetic polymorphisms in GSTM1,GSTP1,and GSTT1 and the risk for breast cancer:results from the Shanghai Breast Cancer Study and meta-analysis.Cancer Epidemiol Biomarkers Prev,2004,13(2):197-204.
|
| 11 |
Sull JW,Ohrr H,Kang DR,et al.Glutathione S-transferase M1 status and breast cancer risk:a meta-analysis.Yonsei Med J,2004,45(4):683-689.
|
| 12 |
Vogl FD, Taioli E, Maugard C, et al. Glutathione S-transferases M1, T1, and P1 and breast cancer: a pooled analysis. Cancer Epidemiol Biomarkers Prev,2004,13(9):1473-1479.
|
| 13 |
Yu KD,Di GH,Fan L,et al.A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer.Faseb J,2009,In press.
|
| 14 |
Park SK,Yim DS,Yoon KS,et al.Combined effect of GSTM1,GSTT1,and COMT genotypes in individual breast cancer risk. Breast Cancer Res Treat,2004,88(1):55-62.
|
| 15 |
Chacko P,Joseph T,Mathew BS,et al.Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.Mutat Res,2005,581(1-2):153-163.
|
| 16 |
Helzlsouer KJ,Selmin O,Huang HY,et al.Association between glutathione S-transferase M1,P1,and T1 genetic polymorphisms and de velopment of breast cancer.J Natl Cancer Inst,1998,90(7):512-518.
|
| 17 |
Mitrunen K, Jourenkova N, Kataja V, et al. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.Cancer Epidemiol Biomarkers Prev,2001,10(3):229-236.
|
| 18 |
Roodi N,Dupont WD,Moore JH,et al.Association of homozygous wild-type glutathione S-transferase M1 genotype with increased breast cancer risk.Cancer Res,2004,64(4):1233-1236.
|
| 19 |
Reed DJ.Glutathione:toxicological implications.Annu Rev Pharmacol Toxicol,1990,30:603-631.
|
| 20 |
Talalay P.Mechanisms of induction of enzymes that protect against ch emical carcinogenesis.Adv Enzyme Regul,1989,28:237-250.
|
| 21 |
Jaiswal AK.Characterization and partial purification of microsomal N AD(P)H:quinone oxidoreductases.Arch Biochem Biophys,2000,375(1):62-68.
|
| 22 |
Fagerholm R,Hofstetter B,Tommiska J,et al.NAD(P)H:quinone oxidoreductase 1 NQO1*2 genotype(P187S)is a strong prognostic and predictive factor in breast cancer.Nat Genet,2008,40(7):844-853.
|
| 23 |
Long DJ,Jaiswal AK.NRH:quinone oxidoreductase2(NQO2).Chem Biol Interact,2000,129(1-2):99-112.
|
| 24 |
Celli CM,Tran N,Knox R,et al.NRH:quinone oxidoreductase 2(NQO2)catalyzes metabolic activation of quinones and anti-tumor drugs.Biochem Pharmacol,2006,72(3):366-376.
|
| 25 |
Yu KD,Di GH,Yuan WT,et al.Functional Polymorphisms,Altered Gene Expression and Genetic Association Link NRH:Quinone Oxidoreductase 2 to Breast Cancer with Wild-type p53.Hum Mol Genet,2009.In press.
|
| 26 |
Yu KD, Di GH, Fan L, et al. Caution regarding genotyping metho dology for a triallelic polymorphism in the novel breast cancer susceptibility gene NQO2.Breast Cancer Res Treat,2009,In press.
|
| 27 |
Easton DF,Eeles RA.Genome-wide association studies in cancer.Hum Mol Genet,2008,17(R2):R109-115.
|
| 28 |
Easton DF,Pooley KA,Dunning AM,et al.Genome-wide association study identifies novel breast cancer susceptibility loci. Nature, 2007, 447(7148):1087-1093.
|
| 29 |
Stacey SN, Manolescu A, Sulem P, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet,2008,40(6):703-706.
|
| 30 |
Yu KD,Di GH,Fan L,et al.Test of Hardy-Weinberg equilibrium in breast cancer case-control studies:an issue may influence the conclusions.Breast Cancer Res Treat,2009.In press.
|